CRISPR Therapeutic Regulatory Support and Expertise
CRISPR cell and gene therapies are revolutionizing medicine, but the journey to clinical trials can be complex. With the expertise of Synthego's regulatory team, CRISPR regulations don’t have to be daunting - you can now transition your therapy from the lab to the clinic seamlessly.
Our regulatory professionals continuously navigate the evolving landscape of CRISPR regulations to refine our products, processes, and regulatory services, ensuring a smooth progression from discovery to delivery for developers of genomic medicines. We offer comprehensive support for the intricacies of CRISPR regulations for these therapies, from CMC Module 3 completion to direct interactions with health authorities, including the FDA and EMA.
By partnering with Synthego, you'll access updated guidance on CRISPR regulations tailored to every phase of your therapeutic journey, so you can focus on groundbreaking science.
Expedite Approval with Synthego's Drug Master File for sgRNAs
Synthego supports your regulatory documentation with a Drug Master File for GMP sgRNAs, filed with the FDA. Our DMF streamlines the preparation of regulatory documentation, enhancing your submission's success rate and expediting reviews. GMP sgRNAs are critical components of CRISPR therapies and are therefore subject to stringent regulatory requirements. Our DMF addresses the manufacture, handling, and storage of GMP sgRNAs, offering a robust resource for your IND, BLA, or NDA applications.
Leverage Proactive Regulatory Intelligence for CRISPR Success
Proactive regulatory intelligence is what sets Synthego apart. Our approach involves active industry monitoring and strategic analysis, providing valuable insights for navigating CRISPR regulations. This intelligence encompasses FDA guidances, interpretations of regulatory feedback, observance of peer activities, and industry developments.
Synthego’s regulatory excellence draws on our extensive experience within the cell and gene therapy space. From FDA and EMA interactions to adapting regulatory strategies in real-time to meet your changing needs, our regulatory experts equip you with the foresight needed for a smooth and successful CRISPR therapeutic approval process. Don’t let complex CRISPR regulations set you back. Our regulatory support means you won’t just keep pace with regulatory changes—you’ll stay ahead.